The global hematology market is projected to grow substantially due to the new breakthroughs in areas such as stem cell research, genetic therapies, hemoglobinopathies, proteomics, pharmacogenomics, and bleeding disorders, in the coming years. Similarly, factors such as the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the hematology market. The emerging countries are expected to outperform the U.S. and European countries. This is mainly due to the increase in major hospital chains opening new centers in major cities as well as an increase in government expenditure being used to purchase automated hematological analyzers and reagents.
Hematological tests require a lot of mixing and agitation, which is difficult to do manually and hence, automatic mixing and agitation can be conducted with the help of these instruments. Hematology equipment also includes software that helps make data entry easy. For example, Beckman Coulter’s UniCel DxH Slidemaker Stainer Cellular Analysis System provides the most advanced slide-making technology with lean efficiency. This technology has a load-and-go feature, which makes slide-making very easy. It is supported by the DxH SMS software that provides thermal printing technology and 2D barcode scanning that helps to increase the overall productivity of laboratories. Thus, automation is the biggest factor driving the growth of the hematology market as it helps in the reduction of cost, time, and labor.
The Centers for Medicare & Medicaid Services (CMS) has estimated that the healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, the growing awareness and an increasing middle-class population, with more disposable incomes to spend on healthcare, are the driving factors for the growth of coagulation market.
The report analyzes the market by 2 segments, namely, hematology reagents and hematology instruments. These two segments experienced a positive growth till 2013, with a total market value of $4.3 billion, comprising $3.6 billion for reagents and $0.6 billion for instruments, and growing at a CAGR of 7.3%.
The Americas commanded the largest share of 41.75% of the global hematology market at an estimated $1,810.4 million in 2013, expected to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second largest market. Germany commanded the largest share of 20% of the European hematology market at an estimated $272.8 million in 2013, and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asian hematology market is growing in double digits and will continue to grow in the coming years. China commanded the largest share of 53% of the Asian hematology market at an estimated $216.0 million in 2013, and is expected to reach $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies operating in hematology market, and extensively covered in this report, are Abbott Laboratories, Inc., Beckman Coulter, CellaVision, HemoCue, Horiba, Siemens Healthcare, Sysmex Corporation. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Along with market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
- The unmet needs, revenue pockets, and potential areas for expansion hematology market
- A comprehensive review of the key suppliers of analyzers, POC, and slide & imaging manufacturers
Extensive Market Data
- CBC count test volumes
- Hematology analyzer market by client segments
- Hematology analyzers revenue breakdown
- Digital imaging market share
Current and Emerging Products
- An analysis of current and emerging hematology and immunodiagnostic tests
- A review of current instrumentation technologies in hematology, and feature comparison
of high-, medium-, and low-volume/POC analyzers
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Infectious disease
4.2 Auto-immune Diseases
4.3 Nephrological diseases
4.4 Diabetes mellitus
4.7 Cardiovascular Disorders
4.8 Drug Testing
4.9 Other Applications
4.10 Blood Screening
5 By Endusers
5.2 Medical & Diagnostic Laboratories
5.3 Patient Self Testing
5.4 Point of Care Testing
5.6 Other End-Users
6 By Products
6.2 Hematology Cell Counters
6.3 Hematology Analyzers
6.4 Immuno Hematology
6.5 Hematology Reagents
6.6 Hematology Services
6.7 Hematology Rapid Testing
7 By Geographies
7.5 Rest of World
8 By Companies
8.1 Siemens AG Healthcare
8.2 Johnson & Johnson
8.3 Beckman Coulter, Inc.
8.4 Abbott Laboratories
8.5 Thermo Fisher Scientific
8.6 Roche 454
8.7 Other Companies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Blood and Hematology Cell Counters, Hematology Analyzers, Immuno Hematology, Hematology Reagents, Hematology Services, Hematology Rapid Testing and Hemostasis adds up to total
Europe holds second largest market position after North America. Germany commanded the largest share 20% of the Europe hematology market at an estimated $272.8 million in 2013 and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The report “European Hematology Market forecast for 2018 “analyzes the market by 2 segments such as hematology reagents and hematology instruments.
North America Hematology
North America commanded the largest share 41.75% of the Global hematology market at an estimated $1810.4 million in 2013 and are expected to reach $2479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments.
Asian Hematology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of Asian hematology market at an estimated $216.0 million in 2013 and is expected to reach $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018. The report “Asian Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments.